Literature DB >> 2753407

Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum.

Y R Mahida1, S Patel, P Gionchetti, D Vaux, D P Jewell.   

Abstract

The aim of this study was to characterise human intestinal macrophages in normal and inflamed ileum and colon. Immunoperoxidase staining with a panel of monoclonal antibodies and histochemical staining for acid phosphatase and non-specific esterase was performed. In the superficial lamina propria, normal colonic macrophages were larger and more strongly positive for acid phosphatase and non-specific esterase than those in normal terminal ileum. There were more macrophages staining with monoclonal antibody RFD1 in the superficial lamina propria of the latter. Studies in inflammatory bowel disease tissue showed the presence of macrophages staining with monoclonal antibodies RFD9 and 3G8 which were rarely present in normal tissue and represented a different pattern from that seen in infectious colitis. Studies on isolated intestinal macrophages confirmed the findings in tissue sections. Subpopulations of intestinal macrophages are likely to have different functional roles. Phenotypic changes during inflammation may be induced by mediators of inflammation or may represent a recently recruited population of cells.

Entities:  

Mesh:

Year:  1989        PMID: 2753407      PMCID: PMC1434137          DOI: 10.1136/gut.30.6.826

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  The Microbial ecology of the upper small bowel.

Authors:  M D Dickman; A R Chappelka; R W Schaedler
Journal:  Am J Gastroenterol       Date:  1976-01       Impact factor: 10.864

2.  Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man.

Authors:  S L Gorbach; L Nahas; P I Lerner; L Weinstein
Journal:  Gastroenterology       Date:  1967-12       Impact factor: 22.682

3.  The structure of the colonic mucosa. The epithelium and subepithelial reticulohistiocytic complex.

Authors:  W L Donnellan
Journal:  Gastroenterology       Date:  1965-11       Impact factor: 22.682

4.  Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells.

Authors:  B Perussia; G Trinchieri
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

Review 5.  Antigen presenting cells in situ: their identification and involvement in immunopathology.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

6.  Isolation and functional characterization of human intestinal mucosal lymphoid cells.

Authors:  D M Bull; M A Bookman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

7.  Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength.

Authors:  D H Jones; R J Looney; C L Anderson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Human neutrophil Fc gamma receptor distribution and structure.

Authors:  H B Fleit; S D Wright; J C Unkeless
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages.

Authors:  W C Van Voorhis; R M Steinman; L S Hair; J Luban; M D Witmer; S Koide; Z A Cohn
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  52 in total

1.  Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.

Authors:  T Kühbacher; P Gionchetti; J Hampe; U Helwig; P Rosenstiel; M Campieri; H J Buhr; S Schreiber
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

3.  Macrophage activity in inflammatory bowel disease.

Authors:  Y R Mahida; D P Jewell
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 4.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

5.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

6.  Interleukin-2 receptor expression.

Authors:  Y R Mahida
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

7.  Location of nitroblue tetrazolium-reducing activity in human colonic mucosa obtained by biopsy.

Authors:  N Oshitani; A Kitano; H Okabe; S Nakamura; T Matsumoto; K Kobayashi
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

8.  Location of superoxide anion generation in human colonic mucosa obtained by biopsy.

Authors:  N Oshitani; A Kitano; H Okabe; S Nakamura; T Matsumoto; K Kobayashi
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

9.  Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.

Authors:  G M Forbes; W N Erber; R P Herrmann; J M Davies; B J Collins
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

10.  Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.

Authors:  S S Johal; C P Lambert; J Hammond; P D James; S P Borriello; Y R Mahida
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.